Originally published by our sister publication Pharmacy Practice News
By Gina Shaw
The vast majority of providers accept pharmacist-initiated recommendations to screen for hepatitis B virus in patients started on oral oncolytics, according to a new study presented at NASP 2024, in Nashville, Tenn.